Moonwalk Biosciences
Signal active
Organization
Contact Information
Overview
Moonwalk Biosciences is a genomic medicine startup that aims to provide a new class of precision epigenetic therapeutics. The company is working on the development of a profiling and engineering technology platform that, with the help of advanced artificial intelligence prediction, provides a comprehensive view of the epigenome in health and disease, allowing healthcare providers to take a fresh look at how therapies are discovered and developed.
About
Industries
Biotechnology, Life Science, Biopharma
Founded
2022
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Moonwalk Biosciences headquartered in United States, North America, operates in the Biotechnology, Life Science, Biopharma sector. The company focuses on Biotechnology and has secured $1.4B in funding across 24 round(s). With a team of 1-10 employees, Moonwalk Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Moonwalk Biosciences, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
0
Lead Investors
0
Total Funding Amount
$57.0M
Details
2
Moonwalk Biosciences has raised a total of $57.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Early Stage Venture | 57.0M | ||
| 2023 | Seed |
Investors
Moonwalk Biosciences is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Google Ventures | - | FUNDING ROUND - Google Ventures | 57.0M |
| Robert Nelsen | - | FUNDING ROUND - Robert Nelsen | 57.0M |
| Moonwalk Biosciences | - | FUNDING ROUND - Moonwalk Biosciences | 57.0M |
| ARCH Venture Partners | - | FUNDING ROUND - ARCH Venture Partners | 57.0M |
Recent Activity
There is no recent news or activity for this profile.